Test Price
2,800 AED✅ Home Collection Available
CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test in UAE | 2800 AED | DHA License 1143
Executive Summary & Core Metrics
The advanced NGS‑based genetic test for CDKN1C gene mutations provides definitive molecular diagnosis of Beckwith-Wiedemann syndrome with 99.9% diagnostic sensitivity. We offer VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, post‑test clinical guidance, and direct insurance billing verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based genetic test sequences the entire coding region of the CDKN1C gene to diagnose Beckwith-Wiedemann syndrome—a pediatric overgrowth disorder with increased embryonal tumor risk. The test provides comprehensive coverage of all coding exons and splice sites, enabling detection of single‑nucleotide variants and small insertions/deletions with >99.9% sensitivity.
| Feature | Our NGS Test | Sanger Sequencing (Alternative) |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) | Sanger Sequencing (single‑gene) |
| Coverage | Full CDKN1C coding exons ± splice sites | Limited to known familial variants or selected hotspot exons |
| Sensitivity | >99.9% for SNVs, small indels | ~95% within targeted regions |
| Turnaround Time | 3 to 4 Weeks | 2 to 3 Weeks |
| Price | 2800 AED | 1800‑2500 AED (may vary) |
| Clinical Utility | Comprehensive diagnosis and cancer risk stratification | Confirms known familial mutation only |
Physician Insight & Safety Protocols
“This NGS test provides precise molecular information for Beckwith-Wiedemann syndrome, but the diagnosis must be integrated with clinical findings including growth parameters, facial features, and abdominal ultrasound. Please do not alter any ongoing treatments without consulting your child’s specialist. The genetic result should be interpreted as part of a comprehensive medical evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue prescribed medications without consulting your physician. Genetic test results are not a substitute for ongoing medical management. Always discuss any changes with your treating doctor.
Exclusion Criteria & Safety Red Flags
- Minors without legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019.
- Inability to provide an adequate peripheral whole blood or extracted DNA sample.
- Active untreated acute illness that may interfere with sample integrity (e.g., severe sepsis).
🚨 Emergency Red Flags (Seek Immediate Care)
- Rapidly enlarging abdominal mass or flank swelling.
- Frank hematuria or unexplained pallor (suspicion of Wilms tumor).
- Persistent high fever with abdominal distension.
- Do not delay medical evaluation while waiting for genetic results.
Patient FAQ & Clinical Guidance
1. What is the purpose of the CDKN1C gene test for Beckwith-Wiedemann syndrome?
This advanced NGS test identifies disease‑causing variants in the CDKN1C gene, confirming a molecular diagnosis of Beckwith-Wiedemann syndrome and guiding personalized cancer surveillance strategies. The test is particularly valuable for early detection of embryonal tumors such as Wilms tumor.
2. How long does it take to receive my genetic test results?
Results are typically available within 3 to 4 weeks from sample receipt. This timeframe ensures thorough sequencing, bioinformatic analysis, and clinical interpretation by our expert geneticists.
3. Is the genetic test covered by health insurance in the UAE?
Many UAE health insurance plans cover diagnostic genetic testing when deemed medically necessary. Our team provides direct billing verification and assists with pre‑authorization via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test complies with all applicable UAE federal laws, including Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is handled securely, and sample processing is performed in accordance with international standards. Your genetic information is protected under strict confidentiality protocols.
Clinical & Logistical Metadata
| Test Name | CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Q87.3 (Beckwith-Wiedemann syndrome) |
| LOINC Code | 94233-2 (CDKN1C gene mutation analysis) |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No. 1143 | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians